Standout Papers

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic sq... 2013 2026 2017 2021 310
  1. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial (2013)
    Jan B. Vermorken, Ірина Давиденко et al. The Lancet Oncology

Citation Impact

4 by Nobel laureates 3 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Colorectal cancer
2024 Standout
PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer
2024 Standout
2 intermediate papers

Works of B. Stein being referenced

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
2013 Standout
Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial
1995

Author Peers

Author Oncology PRM Epidemiology OSM Last Decade Papers Cites
B. Stein 1030 259 56 518 27 1.4k
Shunichi Oka 1 11 4 1 12 329
Valentina Magagnin 11 5 6 301
AD Cembella 3 8 554
Judi Randi 14 375
Silvia Espejel 97 13 20 1 8 654

All Works

Loading papers...

Rankless by CCL
2026